Loading data
MENSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 813 k USD | 927 k USD | 1.07 m USD |
| Operating profit | -2.61 m USD | -2.06 m USD | -2.8 m USD |
| Profit before tax | -4.67 m USD | -3.02 m USD | -4.4 m USD |
| Net income (reported basis) | -4.67 m USD | -3.02 m USD | -4.4 m USD |
| Basic earnings per share | -0.06 USD/share | -0.04 USD/share | -0.06 USD/share |
| Diluted earnings per share | -0.06 USD/share | -0.04 USD/share | -0.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.